- Presentations
- 2
- Markets
- 1
Jardiance is a brand of Empagliflozin marketed by Boehringer Ingelheim Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Empagliflozin
- Brand owner
- Boehringer Ingelheim Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 10 mg tablet, 25 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Jardiance 10 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
| Jardiance 25 mg tabletOral | Boehringer Ingelheim Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Jardiance
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.